dual gip and glp-1 receptor agonist Free Comparison Chart: GIP/GLP-1 Agonists for Type 2 Diabetes π Link in bio #FOAMed #Type2Diabetes #GLP1 Tirzepatide's Unique Mechanism of Action
Description
doi: 10.23736/S2724-6507.20.03369-6 135 FilippatosTDDerdemezisCSGaziIFNakouESMikhailidisDPElisafMS

12, Dec

& Cheng, X

PEX-168, Polyethylene glycol loxenatide

In diabetes care, GLP-1 receptor agonists are often evaluated within a framework that prioritizes prevention of complications such as cardiovascular disease, nephropathy, and retinopathy
